Keep your attorney updated on any changes in your condition
FDA Indications and BMI Requirements Tirzepatide is FDA approved as Mounjaro for adults with type 2 diabetes and as Zepbound for adults with chronic weight management when BMI is 30 kg/m or 27 kg/m with a weight-related condition (e.g., hypertension, dyslipidemia, T2D, OSA, CVD)
Studies show that some coffee metabolites lower glutathione levels
Classification of natural products used in GI disorders Natural products have been at the forefront of traditional and integrative approaches to GI care
What this means in practice: a prospective patient can complete intake, pay the program fee, and still be determined medically ineligible by the clinician at Stage 2
Potential Risks: The Gastroparesis Concern The most significant safety concern regarding this combination involves the digestive tract